Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15


Pharmaceutical stability of colloidal saccharated iron oxide injection in normal saline.

Hira D, Suzuki A, Kono Y, Shimokawa K, Matsuoka S, Hasumoto KY, Kawahara H, Onoue M, Fujita T, Okano T, Kakumoto M.

J Pharm Health Care Sci. 2018 Jul 25;4:21. doi: 10.1186/s40780-018-0116-0. eCollection 2018.


Fractional absorption of active absorbable algal calcium (AAACa) and calcium carbonate measured by a dual stable-isotope method.

Uenishi K, Fujita T, Ishida H, Fujii Y, Ohue M, Kaji H, Hirai M, Kakumoto M, Abrams SA.

Nutrients. 2010 Jul;2(7):752-61. doi: 10.3390/nu2070752. Epub 2010 Jul 12.


Effects of alpha-adrenoceptor antagonist doxazosin on MDR1-mediated multidrug resistance and transcellular transport.

Takara K, Sakaeda T, Kakumoto M, Tanigawara Y, Kobayashi H, Okumura K, Ohnishi N, Yokoyama T.

Oncol Res. 2009;17(11-12):527-33.


Change in pharmacokinetics of model compounds with different elimination processes in rats during hypothermia.

Nishida K, Okazaki M, Sakamoto R, Inaoka N, Miyake H, Fumoto S, Nakamura J, Nakashima M, Sasaki H, Kakumoto M, Sakaeda T.

Biol Pharm Bull. 2007 Sep;30(9):1763-7.


Haloperidol is an inhibitor but not substrate for MDR1/P-glycoprotein.

Iwaki K, Sakaeda T, Kakumoto M, Nakamura T, Komoto C, Okamura N, Nishiguchi K, Shiraki T, Horinouchi M, Okumura K.

J Pharm Pharmacol. 2006 Dec;58(12):1617-22.


Effect of therapeutic moderate hypothermia on multi-drug resistance protein 1-mediated transepithelial transport of drugs.

Jin JS, Sakaeda T, Kakumoto M, Nishiguchi K, Nakamura T, Okamura N, Okumura K.

Neurol Med Chir (Tokyo). 2006 Jul;46(7):321-7; discussion 327.


Intravenous infusion of an antisense oligonucleotide results in exon skipping in muscle dystrophin mRNA of Duchenne muscular dystrophy.

Takeshima Y, Yagi M, Wada H, Ishibashi K, Nishiyama A, Kakumoto M, Sakaeda T, Saura R, Okumura K, Matsuo M.

Pediatr Res. 2006 May;59(5):690-4.


Effects of acid and lactone forms of eight HMG-CoA reductase inhibitors on CYP-mediated metabolism and MDR1-mediated transport.

Sakaeda T, Fujino H, Komoto C, Kakumoto M, Jin JS, Iwaki K, Nishiguchi K, Nakamura T, Okamura N, Okumura K.

Pharm Res. 2006 Mar;23(3):506-12. Epub 2006 Jan 1.


Effect of micafungin on cytochrome P450 3A4 and multidrug resistance protein 1 activities, and its comparison with azole antifungal drugs.

Sakaeda T, Iwaki K, Kakumoto M, Nishikawa M, Niwa T, Jin JS, Nakamura T, Nishiguchi K, Okamura N, Okumura K.

J Pharm Pharmacol. 2005 Jun;57(6):759-64.


Effects of carvedilol on MDR1-mediated multidrug resistance: comparison with verapamil.

Kakumoto M, Sakaeda T, Takara K, Nakamura T, Kita T, Yagami T, Kobayashi H, Okamura N, Okumura K.

Cancer Sci. 2003 Jan;94(1):81-6.


Different contribution of CYP2C19 in the in vitro metabolism of three proton pump inhibitors.

Kita T, Sakaeda T, Baba T, Aoyama N, Kakumoto M, Kurimoto Y, Kawahara Y, Okamura N, Kirita S, Kasuga M, Okumura K.

Biol Pharm Bull. 2003 Mar;26(3):386-90.


Effects of various storage conditions and alterations of antioxidant contents on chromatic aberration of hydroquinone ointment.

Matsubayashi T, Sakaeda T, Kita T, Nakamura T, Kakumoto M, Funasaka Y, Ichihashi M, Fujita T, Kamiyama F, Yamamoto A, Nordlund JJ, Kaneko M, Iida A, Okumura K.

Biol Pharm Bull. 2003 Jan;26(1):120-2.


MDR1-mediated interaction of digoxin with antiarrhythmic or antianginal drugs.

Kakumoto M, Takara K, Sakaeda T, Tanigawara Y, Kita T, Okumura K.

Biol Pharm Bull. 2002 Dec;25(12):1604-7.


Simvastatin and lovastatin, but not pravastatin, interact with MDR1.

Sakaeda T, Takara K, Kakumoto M, Ohmoto N, Nakamura T, Iwaki K, Tanigawara Y, Okumura K.

J Pharm Pharmacol. 2002 Mar;54(3):419-23.


Interaction of digoxin with antihypertensive drugs via MDR1.

Takara K, Kakumoto M, Tanigawara Y, Funakoshi J, Sakaeda T, Okumura K.

Life Sci. 2002 Feb 15;70(13):1491-500.


Supplemental Content

Loading ...
Support Center